Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)

CNY 7.09

(-0.42%)

Market Cap (In CNY)

3.83 Billion

Revenue (In CNY)

2.31 Billion

Net Income (In CNY)

57 Million

Avg. Volume

4.12 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.65-8.87
PE
-
EPS
-
Beta Value
0.529
ISIN
CNE000000453
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Feng Bin
Employee Count
-
Website
https://www.gzsq.com
Ipo Date
1992-08-20
Details
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, and anti-fungal drugs. Its products include prescription drugs and OTC products. The company was founded in 1992 and is based in Shanghai, China.